DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trial Imaging Market Size, Share & Trends Analysis Report by Service (Clinical Trial Design & Consultation Services, Reading & Analytical Services), End-use, Application, Region, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The global clinical trial imaging market size is expected to reach USD 1.97 billion by 2030, registering a CAGR of 7.60% during the forecast period, according to the report. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.
The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.
Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility
Clinical Trial Imaging Market Report Highlights
- Project and Data Management Services held the largest share in 2023 due to the growing requirement for data management and workflow for clinical trial imaging
- Operational imaging services held a significant share in 2023 and include imaging modalities such as MRI, CT scan, Ultrasound, Optical Coherence Tomography (OCT), X-rays, and others
- The oncology segment held the largest share in 2023. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
- CROs held the largest share in 2023 due to increasing investments in the field of research and development, snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time, and patent expiration
- North America dominated this market with the largest share in 2023 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.
Key Market Dynamics
Market Driver Analysis
- Growing number of pharmaceutical and biotechnological companies
- Growing number of contract research organizations (CRO)
- Increasing research and development investments
Market Restraint Analysis
- High cost of machinery and installations
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 190 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $1.14 Billion |
| Forecasted Market Value (USD) by 2030 | $1.97 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global
|
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.5. X-ray Systems Market Analysis Tools
Chapter 4. Clinical Trial Imaging Market: Service Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Clinical Trial Design and Consultation Services
4.1.2. Reading and Analytical Services
4.1.3. Operational Imaging
4.1.4. System and Technology Support Services
4.1.5. Project and Data Management
4.2. Services Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Clinical Trial Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Clinical Trial Design and Consultation Services
4.5.2. Reading and Analytical Services
4.5.3. Operational Imaging Services
4.5.3.2. Computed Tomography (CT) Scan
4.5.3.3. Magnetic Resonance Imaging (MRI)
4.5.3.4. X-rays
4.5.3.5. Ultrasound
4.5.3.6. Optical Coherence Tomography (OCT)
4.5.4. System and Technology Support Services
4.5.5. Project and Data Management
Chapter 5. Clinical Trial Imaging Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Clinical Trial Imaging Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Nonalcoholic Steatohepatitis (NASH)
5.5.2. Chronic Kidney Disease
5.5.3. Diabetes
5.5.4. Cardiovascular Diseases
5.5.5. Ophthalmology
5.5.6. Oncology
5.5.7. Musculoskeletal
5.5.8. Gastroenterology
5.5.9. Pediatrics
Chapter 6. Clinical Trial Imaging Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Biotechnology and Pharmaceutical Companies
6.1.2. Medical Devices Manufacturers
6.1.3. Academic and Government Research Institutes
6.1.4. Contract Research Organization (CRO)
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Clinical Trial Imaging Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Biotechnology and Pharmaceutical Companies
6.5.2. Medical Devices Manufacturers
6.5.3. Academic and Government Research Institutes
6.5.4. Contract Research Organization (CRO)
Chapter 7. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
- Ixico
- Navitas Life Sciences
- Resonance Health
- Proscan Imaging
- Radiant Sage
- Medpace
- Biomedical Systems
- Cardiovascular Imaging Technologies
- Intrinsic Imaging
- Biotelemetry
For more information about this report visit https://www.researchandmarkets.com/r/k86amt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900